Abstract:BACKGROUNDThere is currently considerable interest in the potential value of selective inhibitors of cyclic nucleotide phosphodiesterase 4 in the treatment of asthma. However, whether they influence eosinophilic airway inflammation-associated cough remains unclear. The objective of this study was to investigate the effects of selective phosphodiesterase 4 inhibitor SB207499 on cough response and airway inflammation in guinea pigs sensitized and challenged with ovalbumin.METHODSForty sensitized guinea pigs were randomly divided into four groups: control (n = 10), challenge (n = 10), SB207499 (n = 10) and aminophylline (n = 10), then challenged with aerosol of 1% ovalbumin or saline. Two hours later, animals were intraperitoneally injected with either saline, 25 mg/kg of SB207499 or aminophylline. At the 24th hour, the injection was repeated with 2.5 mg/kg and 25 mg/kg SB207499 or aminophylline, then cough response to inhaled capsaicin and airway responsiveness to methacholine inducing a 150% of the peak airway pressure to the baseline (PC150) was measured. Finally, total cell number and differentials in bronchoalveolar lavage fluid were analysed.RESULTSThe cough frequency per 3 minutes and PC150 in the challenge group were (22 +/- 4) times/3 minutes and (198 +/- 54) microg/ml, which were significantly different from (6 +/- 2) times/3 minutes and (691 +/- 81) microg/ml in the control group (P < 0.05, respectively). The injection of 25 mg/kg SB207499 significantly inhibited the increased cough response and airway hyperresponsiveness, the cough frequency and PC150 in guinea pigs were (13 +/- 2) times/3 minutes and (680 +/- 81) microg/ml (P < 0.05), which differed significantly from (18 +/- 2) times/3 minutes and (400 +/- 86) microg/ml after the administration of the same dose of aminophylline (P < 0.05). The inhibition of SB207499 on cough response was dose-dependent. Similarly, SB207499 decreased the total cell number and percentage of eosinophils in bronchoalveolar lavage fluid to (2.1 +/- 0.5) x 10(6)/ml and (20 +/- 5)% respectively, which were significantly different from (3.2 +/- 0.5) x 10(6)/ml and (29 +/- 5)% in the aminophylline group (P < 0.05, respectively) or (4.2 +/- 0.7) x 10(6)/ml and (35 +/- 4)% in the challenge group (P < 0.05, respectively).CONCLUSIONPhosphodiesterase 4 inhibitor may be more useful than aminophylline for cough associated with eosinophilic airway inflammation via inhibiting airway inflammation and airway hyperresponsiveness.

A multicenter study to evaluate the efficacy and safety of compound methoxyphenamine in the treatment of postinfectious cough

New Strategy for Cough Treatment-Comparison Effect and Safety of Cofetol Cough Syrup with Dextromethorphan Hydrobromide, Chorpheniramine Mateate and Pseudoe Phedrine Hydiochloride Solution in the Treatment of Acute Cough

Clinical Efficacy of Compound Methoxyphenamine Hydrochloride in the Treatment of Cough Variant Asthma

Compound Methoxyphenamine Capsules Treat Asthma with Mild to Moderate Degree

The efficacy of specific neuromodulators on human refractory chronic cough: a systematic review and meta-analysis.

Efficacy and Safety of Dextromethorphan-Chlorpheniramine-pseudoephedrine Solution in Treating Cough Caused by Acute Upper Respiratory Tract Infections in 133 Patients

Evaluation of clinical curative effect and safety of dimemorfan phosphate in the treatment of dry cough

Efficacy and Safety of Modified Sequential Three-Step Empirical Therapy for Chronic Cough

Efficacy of Sequential Three-Step Empirical Therapy for Chronic Cough.

A Phase Ⅱ Clinical Trial for Compound Codeine Phosphate Tablets in Treatment of Moderate or Severe Cough

Efficacy of Oral Specific Neuromodulators on Human Refractory Chronic Cough: A Systematic Review and Meta-analysis

Effects of Phosphodiesterase 4 Inhibitor on Cough Response in Guinea Pigs Sensitized and Challenged with Ovalbumin

Ambroxol hydrochloride spray (Luo Runchang®) in the treatment of acute respiratory infectious diseases: a prospective, multicenter, open label, randomized controlled study

Comparison Effect and Safety of Cofetol Cough Syrup with Compound Codeine Syrup in the Treatment of Infections of Respiratory Tract

A Randomized, Controlled, Multicenter Clinical Trial To Evaluate The Efficacy And Safety Of Oral Sitafloxacin Versus Moxifloxacin In Adult Patients With Community-Acquired Pneumonia

A Prospective Multicenter Randomized Controlled Study on the Efficacy and Safety of Jin-Zheng Oral Solution

Efficacy and Safety of Guaifenesin-Pseudoephedrine Hydrochloride-Codeine Phosphate Oral Solution

Clinical study on the efficacy and safety of Dextromethorphan Hydrochloride, Chlorphenamine Malente, and Ammonium Chloride Syrup on eliminating or relieving the symptoms of acute upper respiratory infection in children

Comparison of Efficacy of Sequential Empirical Three-Step Therapy for Chronic Cough among Different Grades of Hospitals

Clinical benefit of sequential three-step empirical therapy in the management of chronic cough.

Retrospective study of tiotropium in the treatment of postinfection cough